Cargando…
Identification of New Potential Biotherapeutics from Human Gut Microbiota-Derived Bacteria
The role of the gut microbiota in health and disease is well recognized and the microbiota dysbiosis observed in many chronic diseases became a new therapeutic target. The challenge is to get a better insight into the functionality of commensal bacteria and to use this knowledge to select live bioth...
Autores principales: | Cuffaro, Bernardo, Assohoun, Aka L. W., Boutillier, Denise, Peucelle, Véronique, Desramaut, Jérémy, Boudebbouze, Samira, Croyal, Mikael, Waligora-Dupriet, Anne-Judith, Rhimi, Moez, Grangette, Corinne, Maguin, Emmanuelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998412/ https://www.ncbi.nlm.nih.gov/pubmed/33803291 http://dx.doi.org/10.3390/microorganisms9030565 |
Ejemplares similares
-
Characterization of Two Parabacteroides distasonis Candidate Strains as New Live Biotherapeutics against Obesity
por: Cuffaro, Bernardo, et al.
Publicado: (2023) -
In Vitro Characterization of Gut Microbiota-Derived Commensal Strains: Selection of Parabacteroides distasonis Strains Alleviating TNBS-Induced Colitis in Mice
por: Cuffaro, Bernardo, et al.
Publicado: (2020) -
Multiple Selection Criteria for Probiotic Strains with High Potential for Obesity Management
por: Alard, Jeanne, et al.
Publicado: (2021) -
The acid-tolerant L-arabinose isomerase from the mesophilic Shewanella sp. ANA-3 is highly active at low temperatures
por: Rhimi, Moez, et al.
Publicado: (2011) -
Siropins, novel serine protease inhibitors from gut microbiota acting on human proteases involved in inflammatory bowel diseases
por: Mkaouar, Héla, et al.
Publicado: (2016)